Advisory Committee on Immunization Practices (ACIP), 8878 [2012-3481]
Download as PDF
<![CDATA[
8878
Federal Register / Vol. 77, No. 31 / Wednesday, February 15, 2012 / Notices
room accommodates approximately 240
people.
Security Considerations: Due to
increased security requirements CMS
has instituted stringent procedures for
entrance into the building by nongovernment employees. Attendees will
need to present valid government-issued
picture identification, and sign-in at the
security desk upon entering the
building. Attendees who wish to attend
the ICD–9–CM C&M meeting on March
5, 2012, must submit their name and
organization by February 27, 2012, for
inclusion on the visitor list. This visitor
list will be maintained at the front desk
of the CMS building and used by the
guards to admit visitors to the meeting.
Participants who attended previous
ICD–9–CM C&M meetings will no longer
be automatically added to the visitor
list. You must request inclusion of your
name prior to each meeting you attend.
Please register to attend the meeting
on-line at: https://www.cms.hhs.gov/
apps/events/.
Please contact Mady Hue (410–786–
4510 or Marilu.hue@cms.hhs.gov), for
questions about the registration process.
Purpose: The ICD–9–CM Coordination
and Maintenance Committee is a public
forum for the presentation of proposed
modifications to the International
Classification of Diseases, NinthRevision, Clinical Modification.
Matters to be Discussed: Tentative
agenda items include:
March 5, 2012
ICD–9–CM Procedure Topics:
Administration of Fidaxomicin
Placement of Modeling Catheter in
Endovascular Graft Procedure
Injection or Infusion of Glucarpidase
ICD–10 Updates:
ICD–10 MS–DRG Update
ICD–10 HAC Translation List
Impact of ICD–10 MS–DRGs
Implementation
ICD–10–CM Diagnosis Topics:
Atypical femoral fracture
Choking ‘‘game’’
Cognitive sequelae of cerebrovascular
disease
Family history of SIDS
sroberts on DSK5SPTVN1PROD with NOTICES
Addenda
Agenda items are subject to change as
priorities dictate.
Note: CMS and NCHS will no longer
provide paper copies of handouts for the
meeting. Electronic copies of all meeting
materials will be posted on the CMS and
NCHS Web sites prior to the meeting at
https://www.cms.hhs.gov/
ICD9ProviderDiagnosticCodes/03_
meetings.asp#TopOfPage and https://
www.cdc.gov/nchs/icd/icd9cm_
maintenance.htm.
VerDate Mar<15>2010
17:09 Feb 14, 2012
Jkt 226001
Contact Persons for Additional
Information: Donna Pickett, Medical
Systems Administrator, Classifications
and Public Health Data Standards Staff,
NCHS, 3311 Toledo Road, Room 2337,
Hyattsville, Maryland 20782, email
dfp4@cdc.gov, telephone 301–458–4434
(diagnosis); Mady Hue, Health
Insurance Specialist, Division of Acute
Care, CMS, 7500 Security Boulevard,
Baltimore, Maryland 21244, email
marilu.hue@cms.hhs.gov, telephone
410–786–4510 (procedures).
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: February 8, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–3484 Filed 2–14–12; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
Correction
This notice was published in the
Federal Register on February 1, 2012,
Volume 77, Number 21, Page 5026. The
matters to be discussed and times
should read as follows:
Matters To Be Discussed: The agenda
will include discussions on:
meningococcal vaccine, hepatitis B
vaccine, tetanus, diphtheria, and
acellular pertussis (Tdap) vaccine,
influenza, vaccine supply, 13-valent
pneumococcal conjugate vaccine, and
measles-mumps-rubella (MMR) vaccine.
Recommendation vote is scheduled for
Tdap vaccine. Time will be available for
public comment.
Agenda items are subject to change as
priorities dictate.
Times and Dates:
8 a.m.–5 p.m., February 22, 2012.
8 a.m.–12:30 p.m., February 23, 2012.
The Meeting is Web cast live via the
World Wide Web; for instructions and
more information on ACIP please visit
the ACIP Web site: https://www.cdc.gov/
vaccines/recs/acip/.
Contact Person for More Information:
Stephanie B. Thomas, National Center
Frm 00078
Fmt 4703
Dated: February 8, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–3481 Filed 2–14–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
for Immunization and Respiratory
Diseases, CDC, 1600 Clifton Road NE.,
MS–A27, Atlanta, Georgia 30333,
telephone: (404)639–8836; Email
ACIP@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sfmt 4703
Title: Tracking of Participants in the
Head Start Impact Study.
OMB No.: 0970–0229.
Description: The Administration for
Children and Families (ACF) within the
Department of Health and Human
Services (HHS) will collect follow-up
information from children and families
in the Head Start Impact Study. In
anticipation of conducting a future
follow-up for the study, ACF will collect
information necessary to identify
respondents’ current location and
follow-up with respondents in the
future.
The Head Start Impact Study is a
longitudinal study involving 4,667 first
time enrolled three- and four-year-old
preschool children across 84 nationally
representative grantee/delegate
agencies. Participants have been
randomly assigned to either a Head Start
group or a control group. Data collection
for the study began in fall of 2002 and
has been extended through late spring
2008 to include the participants’ 3rd
grade year. Tracking of the participants
has continued every spring beginning in
2009 and ending in 2011.
ACF will continue to examine
outcomes for the sample through the
spring of the participant’s 12th grade
year. To maintain adequate sample size,
telephone interviews will be conducted
in order to update the respondent’s
location and contact information. This
information will be collected from
E:\FR\FM\15FEN1.SGM
15FEN1
]]>Agencies
[Federal Register Volume 77, Number 31 (Wednesday, February 15, 2012)]
[Notices]
[Page 8878]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-3481]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
Correction
This notice was published in the Federal Register on February 1,
2012, Volume 77, Number 21, Page 5026. The matters to be discussed and
times should read as follows:
Matters To Be Discussed: The agenda will include discussions on:
meningococcal vaccine, hepatitis B vaccine, tetanus, diphtheria, and
acellular pertussis (Tdap) vaccine, influenza, vaccine supply, 13-
valent pneumococcal conjugate vaccine, and measles-mumps-rubella (MMR)
vaccine. Recommendation vote is scheduled for Tdap vaccine. Time will
be available for public comment.
Agenda items are subject to change as priorities dictate.
Times and Dates:
8 a.m.-5 p.m., February 22, 2012.
8 a.m.-12:30 p.m., February 23, 2012.
The Meeting is Web cast live via the World Wide Web; for
instructions and more information on ACIP please visit the ACIP Web
site: https://www.cdc.gov/vaccines/recs/acip/.
Contact Person for More Information: Stephanie B. Thomas, National
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton
Road NE., MS-A27, Atlanta, Georgia 30333, telephone: (404)639-8836;
Email ACIP@CDC.GOV.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Dated: February 8, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-3481 Filed 2-14-12; 8:45 am]
BILLING CODE 4163-18-P
